Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system's coordinators, helping other immune cells fight longer and harder.
Researchers have discovered a way to help aging intestines heal themselves using CAR T-cell therapy. By targeting senescent cells that build up over time, the treatment boosted gut regeneration, reduced inflammation, and improved nutrient absorption in mice.
Bret died on Saturday, January 3, 2026, after a prolonged battle with a rare and aggressive form of Hemophagocytic Lymphohistiocytosis (HLH) and T-Cell Lymphoma in Orlando.
Mumbai (Maharashtra) [India], December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic partnership with Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI compa
Kolkata (West Bengal) [India], September 25: In a major milestone for cancer care in Eastern India, doctors at Apollo Multispeciality Hospitals, Kolkata, have successfully treated a 31-year-old engineer with high-risk Pre-B Acute Lymphoblastic Leukemia (ALL) using CAR-T cell therapy. This ma
Burjeel Medical City in Abu Dhabi has announced a major medical breakthrough with the development of an innovative CAR T-cell therapy for blood cancers, which could reduce treatment costs by up to 90 per cent.
People's immune systems deteriorate as they age, making cancer therapies that rely on immune cells difficult to implement. In a new study, researchers from the University of Lausanne (UNIL), the Lausanne University Hospital (CHUV), the Geneva University Hospitals (HUG), and the Ecole Polytec
Immunotherapy research primarily focuses on better recognition of cancer cells by the body's own immune system. Researchers at Amsterdam UMC and Moffitt Cancer Center have taken a different approach.
The researchers have identified a rare type of immune cell, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses against cancer and other chronic infections.
Prolonged illnesses, such as cancer and persistent infections, can fatigue the immune system, causing its frontline defenders, T cells, to lose their ability to act efficiently.
The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor T-cell (CAR-T) therapy under the leadership of Prof. Sandeep Bansal (Medical Superintendent), a novel treatment for certain types of lymphoma and blood cancers.
Researchers at Penn Medicine's Abramson Cancer Centre and the University of Pennsylvania's Perelman School of Medicine have found that a straightforward dietary supplement may offer a novel way to enhance CAR T cell performance.